Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-01-07, Stock:PFE, The news for the past five days is as follows:
2018-12-28: NEWS1: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS2: Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan.NEWS3: After Hours Most Active for Dec 28, 2018 :  ZAYO, BAC, ORCL, QQQ, FDC, PFE, PCG, MSFT, AAPL, DOCU, FOLD, NWL.NEWS4: After Hours Most Active for Dec 28, 2018 :  ZAYO, BAC, ORCL, QQQ, FDC, PFE, PCG, MSFT, AAPL, DOCU, FOLD, NWL.NEWS5: IVV, PFE, UNH, MRK: ETF Inflow Alert.NEWS6: IVV, PFE, UNH, MRK: ETF Inflow Alert.NEWS7: Will AbbVie (ABBV) Shares Regain Lost Momentum in 2019?.NEWS8: Will AbbVie (ABBV) Shares Regain Lost Momentum in 2019?.NEWS9: Will AbbVie (ABBV) Shares Regain Lost Momentum in 2019?.NEWS10: Health Care Sector Update for 12/28/2018: APHA, MESO, HTGM, JNJ, PFE, ABT, MRK, AMGN.NEWS11: Health Care Sector Update for 12/28/2018: APHA, MESO, HTGM, JNJ, PFE, ABT, MRK, AMGN.
2018-12-31: NEWS1: After Hours Most Active for Dec 31, 2018 :  FRC, T, QQQ, MSFT, PFE, SNV, D, GOV, CPB, CSCO, AAPL, MDLZ.NEWS2: After Hours Most Active for Dec 31, 2018 :  FRC, T, QQQ, MSFT, PFE, SNV, D, GOV, CPB, CSCO, AAPL, MDLZ.NEWS3: This Is The Top Dow Stock Of 2018 — And It's Not Even Close.NEWS4: Does Pfizer Have A Multibillion-Dollar Replacement For Opioids?.NEWS5: Stocks Today Brush Off The Bears; Will These 4 Lead The Dow Jones In 2019?.NEWS6: Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference.NEWS7: Health Care Sector Update for 12/31/2018: VTVT, ADMP, MBOT, JNJ, PFE, MRK, ABT, AMGN.NEWS8: Health Care Sector Update for 12/31/2018: VTVT, ADMP, MBOT, JNJ, PFE, MRK, ABT, AMGN.NEWS9: Pfizer Stock Withstood a Health Care Sector Stumble to Be a 2018 Winner.
2019-01-02: NEWS1: The best-performing sector last year could be the top bet for 2019, technician says.NEWS2: The 3 Best Stocks in the Dow Jones in 2018.NEWS3: The 3 Best Stocks in the Dow Jones in 2018.NEWS4: Your first trade for Wednesday, January 2.NEWS5: Health Care Sector Update for 01/02/2019: PRQR, PTLA, NTEC, JNJ, PFE, ABT, MRK, AMGN.NEWS6: Health Care Sector Update for 01/02/2019: PRQR, PTLA, NTEC, JNJ, PFE, ABT, MRK, AMGN.NEWS7: The 3 Best Stocks in the Dow Jones in 2018.NEWS8: Pfizer Could Be a Healthy Option in This Volatile Market.NEWS9: Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for January 03, 2019.NEWS10: Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for January 03, 2019.NEWS11: SNY Named Top 10 SAFE International Dividend Stock.NEWS12: SNY Named Top 10 SAFE International Dividend Stock.NEWS13: This 2019 Market Optimism Is Misplaced: Market Recon.NEWS14: Dow Jones Futures Signal Sell-Off To Open 2019 Stock Market; Trump Says 'Let's Make A Deal'.NEWS15: Dow Jones Futures Dive On China Data; Will 'Make A Deal' Trump Fuel 2019 Market Rally?.NEWS16: Dow Jones Futures Fall On China Data; Will 'Make A Deal' Trump Fuel 2019 Market Rally?.NEWS17: Dow Jones Futures: Will 'Let's Make A Deal' Trump Fuel 2019 Stock Market Rally?.NEWS18: Drugmakers Raise Prices on Hundreds of Medicines.NEWS19: Dow Jones Futures: 'Let's Make A Deal' Trump Fuels 2019 Stock Market Rally.NEWS20: [$$] Drugmakers Raise Prices on Hundreds of Medicines.
2019-01-03: NEWS1: Why Johnson & Johnson Stock is Clearly Set to Rise Again.NEWS2: Why Johnson & Johnson Stock is Clearly Set to Rise Again.NEWS3: 3 Biopharma Stocks to Buy for Their Robust Dividend Yields.NEWS4: 3 Biopharma Stocks to Buy for Their Robust Dividend Yields.NEWS5: Why Johnson & Johnson Stock is Clearly Set to Rise Again.NEWS6: 3 Biopharma Stocks to Buy for Their Robust Dividend Yields.NEWS7: Will Pfizer's (PFE) Stock Keep Up the Momentum in 2019?.NEWS8: Will Pfizer's (PFE) Stock Keep Up the Momentum in 2019?.NEWS9: Will Pfizer's (PFE) Stock Keep Up the Momentum in 2019?.NEWS10: Pfizer Initiates Phase 2b/3 Clinical Trial for PF-06651600, an Oral JAK3 Inhibitor, for the Treatment of Patients with Moderate to Severe Alopecia Areata.
2019-01-04: NEWS1: Bristol To Become Top 5 Pharma — And Other Fallout From Celgene Takeover.NEWS2: Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate.NEWS3: Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate.NEWS4: Nektar, ImaginAb Enter Into Immuno-Oncology Collaboration.NEWS5: Nektar, ImaginAb Enter Into Immuno-Oncology Collaboration.NEWS6: Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate.NEWS7: Health Care Sector Update for 01/04/2019: FLKS, NVAX, ESPR, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 01/04/2019: FLKS, NVAX, ESPR, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Pfizer Begins Pivotal Study on Alopecia Areata Candidate.NEWS10: Pfizer Begins Pivotal Study on Alopecia Areata Candidate.NEWS11: Pfizer Rises 3%.NEWS12: Pfizer Begins Pivotal Study on Alopecia Areata Candidate.NEWS13: Today's Research Reports on Trending Tickers: Pfizer and Bristol-Myers Squibb.

Answer: Rise